TSS Code | Source Site | Study Name | BCR |
---|---|---|---|
01 | International Genomics Consortium | Ovarian serous cystadenocarcinoma | IGC |
02 | MD Anderson Cancer Center | Glioblastoma multiforme | IGC |
04 | Gynecologic Oncology Group | Ovarian serous cystadenocarcinoma | IGC |
05 | Indivumed | Lung adenocarcinoma | IGC |
06 | Henry Ford Hospital | Glioblastoma multiforme | IGC |
07 | TGen | Cell Line Control | IGC |
08 | UCSF | Glioblastoma multiforme | IGC |
09 | UCSF | Ovarian serous cystadenocarcinoma | IGC |
10 | MD Anderson Cancer Center | Ovarian serous cystadenocarcinoma | IGC |
11 | MD Anderson Cancer Center | Lung squamous cell carcinoma | IGC |
12 | Duke | Glioblastoma multiforme | IGC |
13 | Memorial Sloan Kettering | Ovarian serous cystadenocarcinoma | IGC |
14 | Emory University | Glioblastoma multiforme | IGC |
15 | Mayo Clinic - Rochester | Glioblastoma multiforme | IGC |
16 | Toronto Western Hospital | Glioblastoma multiforme | IGC |
17 | Washington University | Lung adenocarcinoma | IGC |
18 | Princess Margaret Hospital (Canada) | Lung squamous cell carcinoma | IGC |
19 | Case Western | Glioblastoma multiforme | IGC |
1Z | Johns Hopkins | Thymoma | NCH |
20 | Fox Chase Cancer Center | Ovarian serous cystadenocarcinoma | IGC |
21 | Fox Chase Cancer Center | Lung squamous cell carcinoma | IGC |
22 | Mayo Clinic - Rochester | Lung squamous cell carcinoma | IGC |
23 | Cedars Sinai | Ovarian serous cystadenocarcinoma | IGC |
24 | Washington University | Ovarian serous cystadenocarcinoma | IGC |
25 | Mayo Clinic - Rochester | Ovarian serous cystadenocarcinoma | IGC |
26 | University of Florida | Glioblastoma multiforme | IGC |
27 | Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta | Glioblastoma multiforme | IGC |
28 | Cedars Sinai | Glioblastoma multiforme | IGC |
29 | Duke | Ovarian serous cystadenocarcinoma | IGC |
2A | Memorial Sloan Kettering Cancer Center | Prostate adenocarcinoma | NCH |
2E | University of Kansas Medical Center | Uterine Corpus Endometrial Carcinoma | NCH |
2F | Erasmus MC | Bladder Urothelial Carcinoma | NCH |
2G | Erasmus MC | Testicular Germ Cell Tumors | NCH |
2H | Erasmus MC | Esophageal carcinoma | NCH |
2J | Mayo Clinic | Pancreatic adenocarcinoma | NCH |
2K | Greenville Health System | Kidney renal papillary cell carcinoma | NCH |
2L | Technical University of Munich | Pancreatic adenocarcinoma | NCH |
2M | Technical University of Munich | Esophageal carcinoma | NCH |
2N | Technical University of Munich | Stomach adenocarcinoma | NCH |
2P | University of California San Diego | Pancreatic adenocarcinoma | NCH |
2V | University of California San Diego | Liver hepatocellular carcinoma | NCH |
2W | University of New Mexico | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
2X | ABS IUPUI | Testicular Germ Cell Tumors | NCH |
2Y | Moffitt Cancer Center | Liver hepatocellular carcinoma | NCH |
2Z | Moffitt Cancer Center | Kidney renal papillary cell carcinoma | NCH |
30 | Harvard | Ovarian serous cystadenocarcinoma | IGC |
31 | Imperial College | Ovarian serous cystadenocarcinoma | IGC |
32 | St. Joseph's Hospital (AZ) | Glioblastoma multiforme | IGC |
33 | Johns Hopkins | Lung squamous cell carcinoma | IGC |
34 | University of Pittsburgh | Lung squamous cell carcinoma | IGC |
35 | Cureline | Lung adenocarcinoma | IGC |
36 | BC Cancer Agency | Ovarian serous cystadenocarcinoma | IGC |
37 | Cureline | Lung squamous cell carcinoma | IGC |
38 | UNC | Lung adenocarcinoma | IGC |
39 | MSKCC | Lung squamous cell carcinoma | IGC |
3A | Moffitt Cancer Center | Pancreatic adenocarcinoma | NCH |
3B | Moffitt Cancer Center | Sarcoma | NCH |
3C | Columbia University | Breast invasive carcinoma | NCH |
3E | Columbia University | Pancreatic adenocarcinoma | NCH |
3G | MD Anderson Cancer Center | Thymoma | NCH |
3H | MD Anderson Cancer Center | Mesothelioma | NCH |
3J | Carle Cancer Center | Breast invasive carcinoma | NCH |
3K | Boston Medical Center | Liver hepatocellular carcinoma | NCH |
3L | Albert Einstein Medical Center | Colon adenocarcinoma | NCH |
3M | University of Kansas Medical Center | Stomach adenocarcinoma | NCH |
3N | Greenville Health System | Skin Cutaneous Melanoma | NCH |
3P | Greenville Health System | Ovarian serous cystadenocarcinoma | NCH |
3Q | Greenville Health Systems | Thymoma | NCH |
3R | University of New Mexico | Sarcoma | NCH |
3S | University of New Mexico | Thymoma | NCH |
3T | Emory University | Thymoma | NCH |
3U | University of Chicago | Mesothelioma | NCH |
3W | University of California San Diego | Sarcoma | NCH |
3X | Alberta Health Services | Cholangiocarcinoma | NCH |
3Z | Mary Bird Perkins Cancer Center - Our Lady of the Lake | Kidney renal clear cell carcinoma | NCH |
41 | Christiana Healthcare | Glioblastoma multiforme | IGC |
42 | Christiana Healthcare | Ovarian serous cystadenocarcinoma | IGC |
43 | Christiana Healthcare | Lung squamous cell carcinoma | IGC |
44 | Christiana Healthcare | Lung adenocarcinoma | IGC |
46 | St. Joseph's Medical Center (MD) | Lung squamous cell carcinoma | IGC |
49 | Johns Hopkins | Lung adenocarcinoma | IGC |
4A | Mary Bird Perkins Cancer Center - Our Lady of the Lake | Kidney renal papillary cell carcinoma | NCH |
4B | Mary Bird Perkins Cancer Center - Our Lady of the Lake | Lung adenocarcinoma | NCH |
4C | Mary Bird Perkins Cancer Center - Our Lady of the Lake | Thyroid carcinoma | NCH |
4D | Molecular Response | Ovarian serous cystadenocarcinoma | NCH |
4E | Molecular Response | Uterine Corpus Endometrial Carcinoma | NCH |
4G | Sapienza University of Rome | Cholangiocarcinoma | NCH |
4H | Proteogenex, Inc. | Breast invasive carcinoma | NCH |
4J | Proteogenex, Inc. | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
4K | Proteogenex, Inc. | Testicular Germ Cell Tumors | NCH |
4L | Proteogenex, Inc. | Prostate adenocarcinoma | NCH |
4N | Mary Bird Perkins Cancer Center - Our Lady of the Lake | Colon adenocarcinoma | NCH |
4P | Duke University | Head and Neck squamous cell carcinoma | NCH |
4Q | Duke University | Sarcoma | NCH |
4R | Duke University | Liver hepatocellular carcinoma | NCH |
4S | Duke University | Prostate adenocarcinoma | NCH |
4T | Duke University | Colon adenocarcinoma | NCH |
4V | Hospital Louis Pradel | Thymoma | NCH |
4W | University of Miami | Glioblastoma multiforme | NCH |
4X | Yale University | Thymoma | NCH |
4Y | Medical College of Wisconsin | Sarcoma | NCH |
4Z | Barretos Cancer Hospital | Bladder Urothelial Carcinoma | NCH |
50 | University of Pittsburgh | Lung adenocarcinoma | IGC |
51 | UNC | Lung squamous cell carcinoma | IGC |
52 | University of Miami | Lung squamous cell carcinoma | IGC |
53 | University of Miami | Lung adenocarcinoma | IGC |
55 | International Genomics Consortium | Lung adenocarcinoma | IGC |
56 | International Genomics Consortium | Lung squamous cell carcinoma | IGC |
57 | International Genomics Consortium | Ovarian serous cystadenocarcinoma | IGC |
58 | Thoraxklinik at University Hospital Heidelberg | Lung squamous cell carcinoma | IGC |
59 | Roswell Park | Ovarian serous cystadenocarcinoma | IGC |
5A | Wake Forest University | Cholangiocarcinoma | NCH |
5B | Medical College of Wisconsin | Uterine Corpus Endometrial Carcinoma | NCH |
5C | Cureline | Liver hepatocellular carcinoma | NCH |
5D | University of Miami | Sarcoma | NCH |
5F | Duke University | Thyroid carcinoma | NCH |
5G | Cleveland Clinic Foundation | Thymoma | NCH |
5H | Retina Consultants Houston | Uveal Melanoma | NCH |
5J | Cureline | Acute Myeloid Leukemia | NCH |
5K | St. Joseph's Hospital AZ | Thymoma | NCH |
5L | University of Sao Paulo | Breast invasive carcinoma | NCH |
5M | University of Sao Paulo | Colon adenocarcinoma | NCH |
5N | University Hospital Erlangen | Bladder Urothelial Carcinoma | NCH |
5P | University Hospital Erlangen | Kidney renal papillary cell carcinoma | NCH |
5Q | Proteogenex, Inc | Pancreatic adenocarcinoma | NCH |
5R | Proteogenex, Inc | Liver hepatocellular carcinoma | NCH |
5S | Holy Cross | Uterine Corpus Endometrial Carcinoma | NCH |
5T | Holy Cross | Breast invasive carcinoma | NCH |
5U | Regina Elena National Cancer Institute | Thymoma | NCH |
5V | Roswell Park | Thymoma | NCH |
5W | University of Alabama | Uterine Corpus Endometrial Carcinoma | NCH |
5X | University of Alabama | Ovarian serous cystadenocarcinoma | NCH |
60 | Roswell Park | Lung squamous cell carcinoma | IGC |
61 | University of Pittsburgh | Ovarian serous cystadenocarcinoma | IGC |
62 | Thoraxklinik at University Hospital Heidelberg | Lung adenocarcinoma | IGC |
63 | Ontario Institute for Cancer Research | Lung squamous cell carcinoma | IGC |
64 | Fox Chase | Lung adenocarcinoma | IGC |
65 | Roswell Park | Glioblastoma multiforme | IGC |
66 | Indivumed | Lung squamous cell carcinoma | IGC |
67 | St Joseph's Medical Center (MD) | Lung adenocarcinoma | IGC |
68 | Washington University - Cleveland Clinic | Lung squamous cell carcinoma | IGC |
69 | Washington University - Cleveland Clinic | Lung adenocarcinoma | IGC |
6A | University of Kansas | Lung squamous cell carcinoma | NCH |
6D | University of Oklahoma HSC | Kidney renal clear cell carcinoma | NCH |
6G | University of Sao Paulo | Rectum adenocarcinoma | NCH |
6H | Test For lcml | Chronic Myelogenous Leukemia | NCH |
70 | ILSBio | Lung squamous cell carcinoma | IGC |
71 | ILSBio | Lung adenocarcinoma | IGC |
72 | NCH | Ovarian serous cystadenocarcinoma | IGC |
73 | Roswell Park | Lung adenocarcinoma | IGC |
74 | Swedish Neurosciences | Glioblastoma multiforme | IGC |
75 | Ontario Institute for Cancer Research (OICR) | Lung adenocarcinoma | IGC |
76 | Thomas Jefferson University | Glioblastoma multiforme | IGC |
77 | Prince Charles Hospital | Lung squamous cell carcinoma | IGC |
78 | Prince Charles Hospital | Lung adenocarcinoma | IGC |
79 | Ontario Institute for Cancer Research (OICR)/Ottawa | Lung squamous cell carcinoma | IGC |
80 | Ontario Institute for Cancer Research (OICR)/Ottawa | Lung adenocarcinoma | IGC |
81 | CHI-Penrose Colorado | Glioblastoma multiforme | IGC |
82 | CHI-Penrose Colorado | Lung squamous cell carcinoma | IGC |
83 | CHI-Penrose Colorado | Lung adenocarcinoma | IGC |
85 | Asterand | Lung squamous cell carcinoma | IGC |
86 | Asterand | Lung adenocarcinoma | IGC |
87 | International Genomics Consortium | Glioblastoma multiforme | IGC |
90 | ABS - IUPUI | Lung squamous cell carcinoma | IGC |
91 | ABS - IUPUI | Lung adenocarcinoma | IGC |
92 | Washington University - St. Louis | Lung squamous cell carcinoma | IGC |
93 | Washington University - St. Louis | Lung adenocarcinoma | IGC |
94 | Washington University - Emory | Lung squamous cell carcinoma | IGC |
95 | Washington University - Emory | Lung adenocarcinoma | IGC |
96 | Washington University - NYU | Lung squamous cell carcinoma | IGC |
97 | Washington University - NYU | Lung adenocarcinoma | IGC |
98 | Washington University - Alabama | Lung squamous cell carcinoma | IGC |
99 | Washington University - Alabama | Lung adenocarcinoma | IGC |
A1 | UCSF | Breast invasive carcinoma | NCH |
A2 | Walter Reed | Breast invasive carcinoma | NCH |
A3 | International Genomics Consortium | Kidney renal clear cell carcinoma | IGC |
A4 | International Genomics Consortium | Kidney renal papillary cell carcinoma | IGC |
A5 | Cedars Sinai | Uterine Corpus Endometrial Carcinoma | NCH |
A6 | Christiana Healthcare | Colon adenocarcinoma | IGC |
A7 | Christiana Healthcare | Breast invasive carcinoma | NCH |
A8 | Indivumed | Breast invasive carcinoma | NCH |
AA | Indivumed | Colon adenocarcinoma | IGC |
AB | Washington University | Acute Myeloid Leukemia | NCH |
AC | International Genomics Consortium | Breast invasive carcinoma | NCH |
AD | International Genomics Consortium | Colon adenocarcinoma | IGC |
AF | Christiana Healthcare | Rectum adenocarcinoma | IGC |
AG | Indivumed | Rectum adenocarcinoma | IGC |
AH | International Genomics Consortium | Rectum adenocarcinoma | IGC |
AJ | International Genomics Conosrtium | Uterine Corpus Endometrial Carcinoma | NCH |
AK | Fox Chase | Kidney renal clear cell carcinoma | IGC |
AL | Fox Chase | Kidney renal papillary cell carcinoma | IGC |
AM | Cureline | Colon adenocarcinoma | IGC |
AN | Cureline | Breast invasive carcinoma | NCH |
AO | MSKCC | Breast invasive carcinoma | NCH |
AP | MSKCC | Uterine Corpus Endometrial Carcinoma | NCH |
AQ | UNC | Breast invasive carcinoma | NCH |
AR | Mayo | Breast invasive carcinoma | NCH |
AS | St. Joseph's Medical Center-(MD) | Kidney renal clear cell carcinoma | IGC |
AT | St. Joseph's Medical Center-(MD) | Kidney renal papillary cell carcinoma | IGC |
AU | St. Joseph's Medical Center-(MD) | Colon adenocarcinoma | IGC |
AV | NCH | Cell Line Control | NCH |
AW | Cureline | Uterine Corpus Endometrial Carcinoma | NCH |
AX | Gynecologic Oncology Group | Uterine Corpus Endometrial Carcinoma | NCH |
AY | UNC | Colon adenocarcinoma | IGC |
AZ | University of Pittsburgh | Colon adenocarcinoma | IGC |
B0 | University of Pittsburgh | Kidney renal clear cell carcinoma | IGC |
B1 | University of Pittsburgh | Kidney renal papillary cell carcinoma | IGC |
B2 | Christiana Healthcare | Kidney renal clear cell carcinoma | IGC |
B3 | Christiana Healthcare | Kidney renal papillary cell carcinoma | IGC |
B4 | Cureline | Kidney renal clear cell carcinoma | IGC |
B5 | Duke | Uterine Corpus Endometrial Carcinoma | NCH |
B6 | Duke | Breast invasive carcinoma | NCH |
B7 | Cureline | Stomach adenocarcinoma | IGC |
B8 | UNC | Kidney renal clear cell carcinoma | IGC |
B9 | UNC | Kidney renal papillary cell carcinoma | IGC |
BA | UNC | Head and Neck squamous cell carcinoma | IGC |
BB | Johns Hopkins | Head and Neck squamous cell carcinoma | IGC |
BC | UNC | Liver hepatocellular carcinoma | NCH |
BD | University of Pittsburgh | Liver hepatocellular carcinoma | NCH |
BF | Cureline | Skin Cutaneous Melanoma | NCH |
BG | University of Pittsburgh | Uterine Corpus Endometrial Carcinoma | NCH |
BH | University of Pittsburgh | Breast invasive carcinoma | NCH |
BI | University of Pittsburgh | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
BJ | University of Pittsburgh | Thyroid carcinoma | IGC |
BK | Christiana Healthcare | Uterine Corpus Endometrial Carcinoma | NCH |
BL | Christiana Healthcare | Bladder Urothelial Carcinoma | NCH |
BM | UNC | Rectum adenocarcinoma | IGC |
BP | MSKCC | Kidney renal clear cell carcinoma | IGC |
BQ | MSKCC | Kidney renal papillary cell carcinoma | IGC |
BR | Asterand | Stomach adenocarcinoma | IGC |
BS | University of Hawaii | Uterine Corpus Endometrial Carcinoma | NCH |
BT | University of Pittsburgh | Bladder Urothelial Carcinoma | NCH |
BW | St. Joseph's Medical Center-(MD) | Liver hepatocellular carcinoma | NCH |
C4 | Indivumed | Bladder Urothelial Carcinoma | NCH |
C5 | Medical College of Wisconsin | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
C8 | ILSBio | Breast invasive carcinoma | NCH |
C9 | ILSBio | Head and Neck squamous cell carcinoma | NCH |
CA | ILSBio | Colon adenocarcinoma | IGC |
CB | ILSBio | Kidney renal clear cell carcinoma | IGC |
CC | ILSBio | Liver hepatocellular carcinoma | NCH |
CD | ILSBio | Stomach adenocarcinoma | IGC |
CE | ILSBio | Thyroid carcinoma | IGC |
CF | ILSBio | Bladder Urothelial Carcinoma | NCH |
CG | Indivumed | Stomach adenocarcinoma | IGC |
CH | Indivumed | Prostate adenocarcinoma | IGC |
CI | University of Pittsburgh | Rectum adenocarcinoma | IGC |
CJ | MD Anderson Cancer Center | Kidney renal clear cell carcinoma | IGC |
CK | Harvard | Colon adenocarcinoma | IGC |
CL | Harvard | Rectum adenocarcinoma | IGC |
CM | MSKCC | Colon adenocarcinoma | IGC |
CN | University of Pittsburgh | Head and Neck squamous cell carcinoma | IGC |
CQ | University Health Network, Toronto | Head and Neck squamous cell carcinoma | IGC |
CR | Vanderbilt University | Head and Neck squamous cell carcinoma | IGC |
CS | Thomas Jefferson University | Brain Lower Grade Glioma | IGC |
CU | UNC | Bladder Urothelial Carcinoma | NCH |
CV | MD Anderson Cancer Center | Head and Neck squamous cell carcinoma | IGC |
CW | Mayo Clinic - Rochester | Kidney renal clear cell carcinoma | IGC |
CX | Medical College of Georgia | Head and Neck squamous cell carcinoma | IGC |
CZ | Harvard | Kidney renal clear cell carcinoma | IGC |
D1 | Mayo Clinic | Uterine Corpus Endometrial Carcinoma | NCH |
D3 | MD Anderson | Skin Cutaneous Melanoma | NCH |
D5 | Greater Poland Cancer Center | Colon adenocarcinoma | IGC |
D6 | Greater Poland Cancer Center | Head and Neck squamous cell carcinoma | IGC |
D7 | Greater Poland Cancer Center | Stomach adenocarcinoma | IGC |
D8 | Greater Poland Cancer Center | Breast invasive carcinoma | NCH |
D9 | Greater Poland Cancer Center | Skin Cutaneous Melanoma | NCH |
DA | Yale | Skin Cutaneous Melanoma | NCH |
DB | Mayo Clinic - Rochester | Brain Lower Grade Glioma | IGC |
DC | MSKCC | Rectum adenocarcinoma | IGC |
DD | Mayo Clinic - Rochester | Liver hepatocellular carcinoma | NCH |
DE | University of North Carolina | Thyroid carcinoma | NCH |
DF | Ontario Institute for Cancer Research | Uterine Corpus Endometrial Carcinoma | NCH |
DG | Ontario Institute for Cancer Research | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
DH | University of Florida | Brain Lower Grade Glioma | IGC |
DI | MD Anderson | Uterine Corpus Endometrial Carcinoma | NCH |
DJ | Memorial Sloan Kettering | Thyroid carcinoma | NCH |
DK | Memorial Sloan Kettering | Bladder Urothelial Carcinoma | NCH |
DM | University Of Michigan | Colon adenocarcinoma | NCH |
DO | Medical College of Georgia | Thyroid carcinoma | NCH |
DQ | University Of Michigan | Head and Neck squamous cell carcinoma | IGC |
DR | University of Hawaii | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
DS | Cedars Sinai | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
DT | ILSBio | Rectum adenocarcinoma | IGC |
DU | Henry Ford Hospital | Brain Lower Grade Glioma | IGC |
DV | NCI Urologic Oncology Branch | Kidney renal clear cell carcinoma | IGC |
DW | NCI Urologic Oncology Branch | Kidney renal papillary cell carcinoma | IGC |
DX | Memorial Sloan Kettering | Sarcoma | NCH |
DY | University Of Michigan | Rectum adenocarcinoma | NCH |
DZ | Mayo Clinic - Rochester | Kidney renal papillary cell carcinoma | IGC |
E1 | Duke | Brain Lower Grade Glioma | IGC |
E2 | Roswell Park | Breast invasive carcinoma | NCH |
E3 | Roswell Park | Thyroid carcinoma | NCH |
E5 | Roswell Park | Bladder Urothelial Carcinoma | NCH |
E6 | Roswell Park | Uterine Corpus Endometrial Carcinoma | NCH |
E7 | Asterand | Bladder Urothelial Carcinoma | NCH |
E8 | Asterand | Thyroid carcinoma | NCH |
E9 | Asterand | Breast invasive carcinoma | NCH |
EA | Asterand | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
EB | Asterand | Skin Cutaneous Melanoma | NCH |
EC | Asterand | Uterine Corpus Endometrial Carcinoma | NCH |
ED | Asterand | Liver hepatocellular carcinoma | NCH |
EE | University of Sydney | Skin Cutaneous Melanoma | NCH |
EF | Cureline | Rectum adenocarcinoma | IGC |
EI | Greater Poland Cancer Center | Rectum adenocarcinoma | IGC |
EJ | University of Pittsburgh | Prostate adenocarcinoma | IGC |
EK | Gynecologic Oncology Group | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
EL | MD Anderson | Thyroid carcinoma | NCH |
EM | University Health Network | Thyroid carcinoma | NCH |
EO | University Health Network | Uterine Corpus Endometrial Carcinoma | NCH |
EP | Christiana Healthcare | Liver hepatocellular carcinoma | NCH |
EQ | Christiana Healthcare | Stomach adenocarcinoma | IGC |
ER | University of Pittsburgh | Skin Cutaneous Melanoma | NCH |
ES | University of Florida | Liver hepatocellular carcinoma | NCH |
ET | Johns Hopkins | Thyroid carcinoma | NCH |
EU | CHI-Penrose Colorado | Kidney renal clear cell carcinoma | IGC |
EV | CHI-Penrose Colorado | Kidney renal papillary cell carcinoma | IGC |
EW | University of Miami | Breast invasive carcinoma | NCH |
EX | University of North Carolina | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
EY | University of North Carolina | Uterine Corpus Endometrial Carcinoma | NCH |
EZ | UNC | Brain Lower Grade Glioma | IGC |
F1 | UNC | Stomach adenocarcinoma | IGC |
F2 | UNC | Pancreatic adenocarcinoma | IGC |
F4 | Asterand | Colon adenocarcinoma | IGC |
F5 | Asterand | Rectum adenocarcinoma | IGC |
F6 | Asterand | Brain Lower Grade Glioma | IGC |
F7 | Asterand | Head and Neck squamous cell carcinoma | IGC |
F9 | Asterand | Kidney renal papillary cell carcinoma | IGC |
FA | Asterand | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | IGC |
FB | Asterand | Pancreatic adenocarcinoma | IGC |
FC | Asterand | Prostate adenocarcinoma | IGC |
FD | BLN - University Of Chicago | Bladder Urothelial Carcinoma | NCH |
FE | Ohio State University | Thyroid carcinoma | NCH |
FF | SingHealth | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | IGC |
FG | Case Western | Brain Lower Grade Glioma | IGC |
FH | CHI-Penrose Colorado | Thyroid carcinoma | NCH |
FI | Washington University | Uterine Corpus Endometrial Carcinoma | NCH |
FJ | BLN - Baylor | Bladder Urothelial Carcinoma | NCH |
FK | Johns Hopkins | Thyroid carcinoma | NCH |
FL | University of Hawaii - Normal Study | Uterine Corpus Endometrial Carcinoma | NCH |
FM | International Genomics Consortium | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | IGC |
FN | International Genomics Consortium | Brain Lower Grade Glioma | IGC |
FP | International Genomics Consortium | Stomach adenocarcinoma | IGC |
FQ | Johns Hopkins | Pancreatic adenocarcinoma | IGC |
FR | University of North Carolina | Skin Cutaneous Melanoma | NCH |
FS | Essen | Skin Cutaneous Melanoma | NCH |
FT | BLN - University of Miami | Bladder Urothelial Carcinoma | NCH |
FU | International Genomics Consortium | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
FV | International Genomics Consortium | Liver hepatocellular carcinoma | NCH |
FW | International Genomics Consortium | Skin Cutaneous Melanoma | NCH |
FX | International Genomics Consortium | Sarcoma | NCH |
FY | International Genomics Consortium | Thyroid carcinoma | NCH |
FZ | University of Pittsburgh | Pancreatic adenocarcinoma | IGC |
G2 | MD Anderson | Bladder Urothelial Carcinoma | NCH |
G3 | Alberta Health Services | Liver hepatocellular carcinoma | NCH |
G4 | Roswell Park | Colon adenocarcinoma | IGC |
G5 | Roswell Park | Rectum adenocarcinoma | IGC |
G6 | Roswell Park | Kidney renal clear cell carcinoma | IGC |
G7 | Roswell Park | Kidney renal papillary cell carcinoma | IGC |
G8 | Roswell Park | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | IGC |
G9 | Roswell Park | Prostate adenocarcinoma | IGC |
GC | International Genomics Consortium | Bladder Urothelial Carcinoma | NCH |
GD | ABS - IUPUI | Bladder Urothelial Carcinoma | NCH |
GE | ABS - IUPUI | Thyroid carcinoma | NCH |
GF | ABS - IUPUI | Skin Cutaneous Melanoma | NCH |
GG | ABS - IUPUI | Uterine Corpus Endometrial Carcinoma | NCH |
GH | ABS - IUPUI | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
GI | ABS - IUPUI | Breast invasive carcinoma | NCH |
GJ | ABS - IUPUI | Liver hepatocellular carcinoma | NCH |
GK | ABS - IUPUI | Kidney renal clear cell carcinoma | IGC |
GL | ABS - IUPUI | Kidney renal papillary cell carcinoma | IGC |
GM | MD Anderson | Breast invasive carcinoma | NCH |
GN | Roswell | Skin Cutaneous Melanoma | NCH |
GP | MD Anderson | Acute Myeloid Leukemia | NCH |
GR | University of Nebraska Medical Center (UNMC) | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | IGC |
GS | Fundacio Clinic per a la Recerca Biomedica | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | IGC |
GU | BLN - UT Southwestern Medical Center at Dallas | Bladder Urothelial Carcinoma | NCH |
GV | BLN - Cleveland Clinic | Bladder Urothelial Carcinoma | NCH |
GZ | BC Cancer Agency | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | IGC |
H1 | Medical College of Georgia | Stomach adenocarcinoma | IGC |
H2 | Christiana Healthcare | Thyroid carcinoma | NCH |
H3 | ABS - IUPUI | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | IGC |
H4 | Medical College of Georgia | Bladder Urothelial Carcinoma | NCH |
H5 | Medical College of Georgia | Uterine Corpus Endometrial Carcinoma | NCH |
H6 | Christiana Healthcare | Pancreatic adenocarcinoma | IGC |
H7 | ABS - IUPUI | Head and Neck squamous cell carcinoma | IGC |
H8 | ABS - IUPUI | Pancreatic adenocarcinoma | IGC |
H9 | ABS - IUPUI | Prostate adenocarcinoma | IGC |
HA | Alberta Health Services | Stomach adenocarcinoma | IGC |
HB | University of North Carolina | Sarcoma | NCH |
HC | International Genomics Consortium | Prostate adenocarcinoma | IGC |
HD | International Genomics Consortium | Head and Neck squamous cell carcinoma | IGC |
HE | Ontario Institute for Cancer Research (OICR) | Kidney renal papillary cell carcinoma | IGC |
HF | Ontario Institute for Cancer Research (OICR) | Stomach adenocarcinoma | IGC |
HG | Roswell Park | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
HH | Fox Chase | Stomach adenocarcinoma | IGC |
HI | Fox Chase | Prostate adenocarcinoma | IGC |
HJ | Fox Chase | Stomach adenocarcinoma | IGC |
HK | Fox Chase | Brain Lower Grade Glioma | IGC |
HL | Fox Chase | Head and Neck squamous cell carcinoma | IGC |
HM | Christiana Healthcare | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
HN | Ontario Institute for Cancer Research (OICR) | Breast invasive carcinoma | NCH |
HP | Ontario Institute for Cancer Research (OICR) | Liver hepatocellular carcinoma | NCH |
HQ | Ontario Institute for Cancer Research (OICR) | Bladder Urothelial Carcinoma | NCH |
HR | Ontario Institute for Cancer Research (OICR) | Skin Cutaneous Melanoma | NCH |
HS | Ontario Institute for Cancer Research (OICR) | Sarcoma | NCH |
HT | Case Western - St Joes | Brain Lower Grade Glioma | IGC |
HU | National Cancer Center Korea | Stomach adenocarcinoma | IGC |
HV | National Cancer Center Korea | Pancreatic adenocarcinoma | IGC |
HW | MSKCC | Brain Lower Grade Glioma | IGC |
HZ | International Genomics Consortium | Pancreatic adenocarcinoma | IGC |
IA | Cleveland Clinic | Kidney renal papillary cell carcinoma | IGC |
IB | Alberta Health Services | Pancreatic adenocarcinoma | IGC |
IC | University of Pittsburgh | Esophageal carcinoma | NCH |
IE | ABS - IUPUI | Sarcoma | NCH |
IF | University of Texas MD Anderson Cancer Center | Sarcoma | NCH |
IG | Asterand | Esophageal carcinoma | NCH |
IH | University of Miami | Skin Cutaneous Melanoma | NCH |
IJ | Christiana Healthcare | Acute Myeloid Leukemia | NCH |
IK | Christiana Healthcare | Brain Lower Grade Glioma | IGC |
IM | University of Miami | Thyroid carcinoma | NCH |
IN | University of Pittsburgh | Stomach adenocarcinoma | IGC |
IP | ABS - IUPUI | Stomach adenocarcinoma | IGC |
IQ | University of Miami | Head and Neck squamous cell carcinoma | IGC |
IR | Memorial Sloan Kettering | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
IS | Memorial Sloan Kettering | Sarcoma | NCH |
IW | Cedars Sinai | Sarcoma | NCH |
IZ | ABS - Lahey Clinic | Kidney renal papillary cell carcinoma | IGC |
J1 | ABS - Lahey Clinic | Lung squamous cell carcinoma | IGC |
J2 | ABS - Lahey Clinic | Lung adenocarcinoma | IGC |
J4 | ABS - Lahey Clinic | Prostate adenocarcinoma | IGC |
J7 | ILSBio | Kidney renal papillary cell carcinoma | IGC |
J8 | Mayo Clinic | Thyroid carcinoma | NCH |
J9 | Melbourne Health | Prostate adenocarcinoma | IGC |
JA | ABS - Research Metrics Pakistan | Head and Neck squamous cell carcinoma | IGC |
JL | ABS - Research Metrics Pakistan | Breast invasive carcinoma | NCH |
JU | BLN - Baylor | Uterine Corpus Endometrial Carcinoma | NCH |
JV | BLN - Baylor | Sarcoma | NCH |
JW | BLN - Baylor | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
JX | Washington University | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
JY | University Health Network | Esophageal carcinoma | NCH |
JZ | University of Rochester | Esophageal carcinoma | NCH |
K1 | University of Pittsburgh | Sarcoma | NCH |
K4 | ABS - Lahey Clinic | Bladder Urothelial Carcinoma | NCH |
K6 | ABS - Lahey Clinic | Uterine Corpus Endometrial Carcinoma | NCH |
K7 | ABS - Lahey Clinic | Liver hepatocellular carcinoma | NCH |
K8 | ABS - Lahey Clinic | Skin Cutaneous Melanoma | NCH |
KA | ABS - Lahey Clinic | Esophageal carcinoma | NCH |
KB | University Health Network, Toronto | Stomach adenocarcinoma | IGC |
KC | Cornell Medical College | Prostate adenocarcinoma | IGC |
KD | Mount Sinai School of Medicine | Sarcoma | NCH |
KE | Mount Sinai School of Medicine | Uterine Corpus Endometrial Carcinoma | NCH |
KF | Christiana Healthcare | Sarcoma | NCH |
KG | Baylor Network | Pancreatic adenocarcinoma | IGC |
KH | Memorial Sloan Kettering | Esophageal carcinoma | NCH |
KJ | University of Miami | Uterine Corpus Endometrial Carcinoma | NCH |
KK | MD Anderson Cancer Center | Prostate adenocarcinoma | IGC |
KL | MSKCC | Kidney Chromophobe | IGC |
KM | NCI Urologic Oncology Branch | Kidney Chromophobe | IGC |
KN | Harvard | Kidney Chromophobe | IGC |
KO | MD Anderson Cancer Center | Kidney Chromophobe | IGC |
KP | British Columbia Cancer Agency | Uterine Corpus Endometrial Carcinoma | NCH |
KQ | Cornell Medical College | Bladder Urothelial Carcinoma | NCH |
KR | University Of Michigan | Liver hepatocellular carcinoma | NCH |
KS | University Of Michigan | Thyroid carcinoma | NCH |
KT | Hartford | Brain Lower Grade Glioma | IGC |
KU | Hartford | Head and Neck squamous cell carcinoma | IGC |
KV | Hartford | Kidney renal papillary cell carcinoma | IGC |
KZ | Hartford | Stomach adenocarcinoma | IGC |
L1 | Hartford | Pancreatic adenocarcinoma | IGC |
L3 | Gundersen Lutheran Health System | Lung squamous cell carcinoma | IGC |
L4 | Gundersen Lutheran Health System | Lung adenocarcinoma | IGC |
L5 | University of Michigan | Esophageal carcinoma | NCH |
L6 | National Institutes of Health | Thyroid carcinoma | NCH |
L7 | Christiana Care | Esophageal carcinoma | NCH |
L8 | University of Miami | Kidney renal papillary cell carcinoma | NCH |
L9 | Candler | Lung adenocarcinoma | IGC |
LA | Candler | Lung squamous cell carcinoma | IGC |
LB | Candler | Pancreatic adenocarcinoma | IGC |
LC | Hartford Hospital | Bladder Urothelial Carcinoma | NCH |
LD | Hartford Hospital | Breast invasive carcinoma | NCH |
LG | Hartford Hospital | Liver hepatocellular carcinoma | NCH |
LH | Hartford Hospital | Skin Cutaneous Melanoma | NCH |
LI | Hartford Hospital | Sarcoma | NCH |
LK | University of Pittsburgh | Mesothelioma | NCH |
LL | Candler | Breast invasive carcinoma | NCH |
LN | ILSBIO | Esophageal carcinoma | NCH |
LP | ILSBIO | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
LQ | Gundersen Lutheran Health System | Breast invasive carcinoma | NCH |
LS | Gundersen Lutheran Health System | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
LT | Gundersen Lutheran Health System | Bladder Urothelial Carcinoma | NCH |
M7 | University of North Carolina | Prostate adenocarcinoma | NCH |
M8 | Ontario Institute for Cancer Research (OICR) | Pancreatic adenocarcinoma | NCH |
M9 | Ontario Institute for Cancer Research (OICR) | Esophageal carcinoma | NCH |
MA | MD Anderson Cancer Center | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
MB | University of Minnesota | Sarcoma | NCH |
ME | University of Minnesota | Lung adenocarcinoma | NCH |
MF | University of Minnesota | Lung squamous cell carcinoma | NCH |
MG | BLN - Baylor | Prostate adenocarcinoma | NCH |
MH | BLN - Baylor | Kidney renal papillary cell carcinoma | NCH |
MI | BLN - Baylor | Liver hepatocellular carcinoma | NCH |
MJ | BLN - Baylor | Sarcoma | NCH |
MK | BLN - Baylor | Thyroid carcinoma | NCH |
ML | BLN - Baylor | Lung squamous cell carcinoma | NCH |
MM | BLN - Baylor | Kidney renal clear cell carcinoma | NCH |
MN | BLN - Baylor | Lung adenocarcinoma | NCH |
MO | ILSBio | Sarcoma | NCH |
MP | Washington University - Mayo Clinic | Lung adenocarcinoma | NCH |
MQ | Washington University - NYU | Mesothelioma | NCH |
MR | University of Minnesota | Liver hepatocellular carcinoma | NCH |
MS | University of Minnesota | Breast invasive carcinoma | NCH |
MT | University of Minnesota | Head and Neck squamous cell carcinoma | NCH |
MU | University of Minnesota | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
MV | University of Minnesota | Bladder Urothelial Carcinoma | NCH |
MW | University of Miami | Kidney renal clear cell carcinoma | NCH |
MX | MSKCC | Stomach adenocarcinoma | NCH |
MY | Montefiore Medical Center | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
MZ | Montefiore Medical Center | Head and Neck squamous cell carcinoma | NCH |
N1 | Montefiore Medical Center | Sarcoma | NCH |
N5 | MSKCC | Uterine Carcinosarcoma | NCH |
N6 | University of Pittsburgh | Uterine Carcinosarcoma | NCH |
N7 | Washington University | Uterine Carcinosarcoma | NCH |
N8 | University of North Carolina | Uterine Carcinosarcoma | NCH |
N9 | MD Anderson | Uterine Carcinosarcoma | NCH |
NA | Duke University | Uterine Carcinosarcoma | NCH |
NB | Washington University - CHUV | Lung adenocarcinoma | NCH |
NC | Washington University - CHUV | Lung squamous cell carcinoma | NCH |
ND | Cedars Sinai | Uterine Carcinosarcoma | NCH |
NF | Mayo Clinic - Rochester | Uterine Carcinosarcoma | NCH |
NG | Roswell Park | Uterine Carcinosarcoma | NCH |
NH | Candler | Colon adenocarcinoma | NCH |
NI | Roswell Park | Liver hepatocellular carcinoma | NCH |
NJ | Washington University - Rush University | Lung adenocarcinoma | NCH |
NK | Washington University - Rush University | Lung squamous cell carcinoma | NCH |
NM | Cambridge BioSource | Head and Neck squamous cell carcinoma | NCH |
NP | International Genomics Consortium | Kidney Chromophobe | NCH |
NQ | International Genomics Consortium | Mesothelioma | NCH |
NS | Gundersen Lutheran Health System | Skin Cutaneous Melanoma | NCH |
O1 | Washington University - CALGB | Lung adenocarcinoma | NCH |
O2 | Washington University - CALGB | Lung squamous cell carcinoma | NCH |
O8 | Saint Mary's Health Care | Liver hepatocellular carcinoma | NCH |
O9 | Saint Mary's Health Care | Kidney renal papillary cell carcinoma | NCH |
OC | Saint Mary's Health Care | Lung squamous cell carcinoma | NCH |
OD | Saint Mary's Health Care | Skin Cutaneous Melanoma | NCH |
OE | Saint Mary's Health Care | Pancreatic adenocarcinoma | NCH |
OJ | Saint Mary's Health Care | Thyroid carcinoma | NCH |
OK | Mount Sinai School of Medicine | Breast invasive carcinoma | NCH |
OL | University of Chicago | Breast invasive carcinoma | NCH |
OR | University of Michigan | Adrenocortical carcinoma | NCH |
OU | Roswell Park | Adrenocortical carcinoma | NCH |
OW | International Genomics Consortium | Miscellaneous | NCH |
OX | University of North Carolina | Glioblastoma multiforme | NCH |
OY | University of North Carolina | Ovarian serous cystadenocarcinoma | NCH |
P3 | Fred Hutchinson | Head and Neck squamous cell carcinoma | NCH |
P4 | MD Anderson Cancer Center | Kidney renal papillary cell carcinoma | NCH |
P5 | Cureline | Brain Lower Grade Glioma | NCH |
P6 | Translational Genomics Research Institute | Adrenocortical carcinoma | NCH |
P7 | Translational Genomics Research Institute | Pheochromocytoma and Paraganglioma | NCH |
P8 | University of Pittsburgh | Pheochromocytoma and Paraganglioma | NCH |
P9 | University of Minnesota | Pancreatic adenocarcinoma | NCH |
PA | University of Minnesota | Adrenocortical carcinoma | NCH |
PB | University of Minnesota | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | NCH |
PC | Fox Chase | Sarcoma | NCH |
PD | Fox Chase | Liver hepatocellular carcinoma | NCH |
PE | Fox Chase | Breast invasive carcinoma | NCH |
PG | Montefiore Medical Center | Uterine Corpus Endometrial Carcinoma | NCH |
PH | Gundersen Lutheran | Acute Myeloid Leukemia | NCH |
PJ | Gundersen Lutheran | Kidney renal papillary cell carcinoma | NCH |
PK | University Health Network | Adrenocortical carcinoma | NCH |
PL | Institute of Human Virology Nigeria | Breast invasive carcinoma | NCH |
PN | Institute of Human Virology Nigeria | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
PQ | University of Colorado Denver | Bladder Urothelial Carcinoma | NCH |
PR | Roswell Park | Pheochromocytoma and Paraganglioma | NCH |
PT | Maine Medical Center | Sarcoma | NCH |
PZ | ABS - Lahey Clinic | Pancreatic adenocarcinoma | NCH |
Q1 | University of Oklahoma HSC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
Q2 | University of Oklahoma HSC | Kidney renal papillary cell carcinoma | NCH |
Q3 | University of Oklahoma HSC | Pancreatic adenocarcinoma | NCH |
Q4 | Emory University | Acute Myeloid Leukemia | NCH |
Q9 | Emory University | Esophageal carcinoma | NCH |
QA | Emory University | Liver hepatocellular carcinoma | NCH |
QB | Emory University | Skin Cutaneous Melanoma | NCH |
QC | Emory University | Sarcoma | NCH |
QD | Emory University | Thyroid carcinoma | NCH |
QF | BLN - Baylor | Uterine Corpus Endometrial Carcinoma | NCH |
QG | BLN - Baylor | Colon adenocarcinoma | NCH |
QH | Fondazione-Besta | Brain Lower Grade Glioma | NCH |
QJ | Mount Sinai School of Medicine | Ovarian serous cystadenocarcinoma | NCH |
QK | Emory University - Winship Cancer Inst. | Head and Neck squamous cell carcinoma | NCH |
QL | University of Chicago | Colon adenocarcinoma | NCH |
QM | University of Oklahoma HSC | Uterine Carcinosarcoma | NCH |
QN | ILSBio | Uterine Carcinosarcoma | NCH |
Roswell Park | Sarcoma | NCH | |
QR | National Institutes of Health | Pheochromocytoma and Paraganglioma | NCH |
QS | Candler | Uterine Corpus Endometrial Carcinoma | NCH |
QT | University of North Carolina | Pheochromocytoma and Paraganglioma | NCH |
QU | Harvard Beth Israel | Prostate adenocarcinoma | NCH |
QV | Instituto Nacional de Cancerologia | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
QW | Instituto Nacional de Cancerologia | Stomach adenocarcinoma | NCH |
R1 | CHI-Penrose Colorado | Colon adenocarcinoma | NCH |
R2 | CHI-Penrose Colorado | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
R3 | CHI-Penrose Colorado | Bladder Urothelial Carcinoma | NCH |
R5 | MD Anderson Cancer Center | Stomach adenocarcinoma | NCH |
R6 | MD Anderson Cancer Center | Esophageal carcinoma | NCH |
R7 | Gundersen Lutheran Health System | Head and Neck squamous cell carcinoma | NCH |
R8 | MD Anderson | Brain Lower Grade Glioma | NCH |
R9 | Candler | Ovarian serous cystadenocarcinoma | NCH |
RA | Candler | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
RB | Emory University | Pancreatic adenocarcinoma | NCH |
RC | University of Utah | Liver hepatocellular carcinoma | NCH |
RD | Peter MacCallum Cancer Center | Stomach adenocarcinoma | NCH |
RE | Peter MacCallum Cancer Center | Esophageal carcinoma | NCH |
RG | Montefiore Medical Center | Liver hepatocellular carcinoma | NCH |
RH | BLN - Baylor | Head and Neck squamous cell carcinoma | NCH |
RL | St. Joseph's Hospital AZ | Pancreatic adenocarcinoma | NCH |
RM | St. Joseph's Hospital AZ | Pheochromocytoma and Paraganglioma | NCH |
RN | St. Joseph's Hospital AZ | Sarcoma | NCH |
RP | St. Joseph's Hospital AZ | Skin Cutaneous Melanoma | NCH |
RQ | St. Joseph's Hospital AZ | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | NCH |
RR | St. Joseph's Hospital AZ | Glioblastoma multiforme | NCH |
RS | Memorial Sloan Kettering Cancer Center | Head and Neck squamous cell carcinoma | NCH |
RT | Cleveland Clinic Foundation | Pheochromocytoma and Paraganglioma | NCH |
RU | Northwestern University | Colon adenocarcinoma | NCH |
RV | Northwestern University | Pancreatic adenocarcinoma | NCH |
RW | Michigan University | Pheochromocytoma and Paraganglioma | NCH |
RX | University of Minnesota | Pheochromocytoma and Paraganglioma | NCH |
RY | University of California San Francisco | Brain Lower Grade Glioma | NCH |
RZ | Wills Eye Institute | Uveal Melanoma | NCH |
S2 | Albert Einstein Medical Center | Lung adenocarcinoma | NCH |
S3 | Albert Einstein Medical Center | Breast invasive carcinoma | NCH |
S4 | University of Chicago | Pancreatic adenocarcinoma | NCH |
S5 | University of Oklahoma HSC | Bladder Urothelial Carcinoma | NCH |
S6 | Gundersen Lutheran Health System | Testicular Germ Cell Tumors | NCH |
S7 | University Hospital Motol | Pheochromocytoma and Paraganglioma | NCH |
S8 | ABS - IUPUI | Esophageal carcinoma | NCH |
S9 | Dept of Neurosurgery at University of Heidelberg | Brain Lower Grade Glioma | NCH |
SA | ABS - IUPUI | Pheochromocytoma and Paraganglioma | NCH |
SB | Baylor College of Medicine | Testicular Germ Cell Tumors | NCH |
SC | Memorial Sloan Kettering | Mesothelioma | NCH |
SD | MD Anderson | Pancreatic adenocarcinoma | NCH |
SE | Boston Medical Center | Pheochromocytoma and Paraganglioma | NCH |
SG | Cleveland Clinic Foundation | Sarcoma | NCH |
SH | Papworth Hospital | Mesothelioma | NCH |
SI | Washington University St. Louis | Sarcoma | NCH |
SJ | Albert Einstein Medical Center | Uterine Corpus Endometrial Carcinoma | NCH |
SK | St. Joseph's Hospital AZ | Colon adenocarcinoma | NCH |
SL | St. Joseph's Hospital AZ | Uterine Corpus Endometrial Carcinoma | NCH |
SN | BLN - Baylor | Testicular Germ Cell Tumors | NCH |
SO | University of Minnesota | Testicular Germ Cell Tumors | NCH |
SP | University Health Network | Pheochromocytoma and Paraganglioma | NCH |
SQ | International Genomics Consortium | Pheochromocytoma and Paraganglioma | NCH |
SR | Tufts Medical Center | Pheochromocytoma and Paraganglioma | NCH |
SS | Medical College of Georgia | Colon adenocarcinoma | NCH |
ST | Global Bioclinical-Moldova | Head and Neck squamous cell carcinoma | NCH |
SU | Global Bioclinical-Moldova | Prostate adenocarcinoma | NCH |
SW | Global Bioclinical-Moldova | Stomach adenocarcinoma | NCH |
SX | Mayo Clinic Arizona | Kidney renal papillary cell carcinoma | NCH |
SY | Mayo Clinic Arizona | Bladder Urothelial Carcinoma | NCH |
T1 | St. Joseph's Hospital Arizona | Liver hepatocellular carcinoma | NCH |
T2 | St. University of Colorado Denver | Head and Neck squamous cell carcinoma | NCH |
T3 | Molecular Response | Head and Neck squamous cell carcinoma | NCH |
T6 | Molecular Response | Lung adenocarcinoma | NCH |
T7 | Molecular Response | Kidney renal clear cell carcinoma | NCH |
T9 | Molecular Response | Colon adenocarcinoma | NCH |
TE | Global BioClinical - Georgia | Skin Cutaneous Melanoma | NCH |
TG | Global BioClinical - Georgia | Head and Neck squamous cell carcinoma | NCH |
TK | Global BioClinical - Georgia | Prostate adenocarcinoma | NCH |
TL | Global BioClinical - Georgia | Stomach adenocarcinoma | NCH |
TM | The University of New South Wales | Brain Lower Grade Glioma | NCH |
TN | Ohio State University | Head and Neck squamous cell carcinoma | NCH |
TP | Maine Medical Center | Prostate adenocarcinoma | NCH |
TQ | University of Sao Paulo | Brain Lower Grade Glioma | NCH |
TR | Global Bioclinical-Moldova | Skin Cutaneous Melanoma | NCH |
TS | University of Pennsylvania | Mesothelioma | NCH |
TT | University of Pennsylvania | Pheochromocytoma and Paraganglioma | NCH |
TV | Wake Forest University | Breast invasive carcinoma | NCH |
UB | UCSF | Liver hepatocellular carcinoma | NCH |
UC | University of Washington | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
UD | University of Western Australia | Mesothelioma | NCH |
UE | Asterand | Sarcoma | NCH |
UF | Barretos Cancer Hospital | Head and Neck squamous cell carcinoma | NCH |
UJ | Boston Medical Center | Lung squamous cell carcinoma | NCH |
UL | Boston Medical Center | Breast invasive carcinoma | NCH |
UN | Boston Medical Center | Kidney renal papillary cell carcinoma | NCH |
UP | Boston Medical Center | Head and Neck squamous cell carcinoma | NCH |
UR | Boston Medical Center | Prostate adenocarcinoma | NCH |
US | Garvan Institute of Medical Research | Pancreatic adenocarcinoma | NCH |
UT | Asbestos Diseases Research Institute | Mesothelioma | NCH |
UU | Mary Bird Perkins Cancer Center - Our Lady of the Lake | Breast invasive carcinoma | NCH |
UV | Capital Biosciences | Liver hepatocellular carcinoma | NCH |
UW | University of North Carolina | Kidney Chromophobe | NCH |
UY | University of California San Francisco | Bladder Urothelial Carcinoma | NCH |
UZ | University of California San Francisco | Kidney renal papillary cell carcinoma | NCH |
V1 | University of California San Francisco | Prostate adenocarcinoma | NCH |
V2 | Cleveland Clinic Foundation | Prostate adenocarcinoma | NCH |
V3 | Cleveland Clinic Foundation | Uveal Melanoma | NCH |
V4 | Institut Curie | Uveal Melanoma | NCH |
V5 | Duke University | Esophageal carcinoma | NCH |
V6 | Duke University | Stomach adenocarcinoma | NCH |
V7 | Medical College of Georgia | Breast invasive carcinoma | NCH |
V8 | Medical College of Georgia | Kidney renal clear cell carcinoma | NCH |
V9 | Medical College of Georgia | Kidney renal papillary cell carcinoma | NCH |
VA | Alliance | Stomach adenocarcinoma | NCH |
VB | Global BioClinical - Georgia | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | NCH |
VD | University of Liverpool | Uveal Melanoma | NCH |
VF | University of Pennsylvania | Testicular Germ Cell Tumors | NCH |
VG | Institute of Human Virology Nigeria | Ovarian serous cystadenocarcinoma | NCH |
VK | Institute of Human Virology Nigeria | Colon adenocarcinoma | NCH |
VL | Institute of Human Virology Nigeria | Rectum adenocarcinoma | NCH |
VM | Huntsman Cancer Institute | Brain Lower Grade Glioma | NCH |
VN | NCI Urologic Oncology Branch | Prostate adenocarcinoma | NCH |
VP | Washington University | Prostate adenocarcinoma | NCH |
VQ | Barretos Cancer Hospital | Stomach adenocarcinoma | NCH |
VR | Barretos Cancer Hospital | Esophageal carcinoma | NCH |
VS | Barretos Cancer Hospital | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
VT | Vanderbilt | Sarcoma | NCH |
VV | John Wayne Cancer Center | Brain Lower Grade Glioma | NCH |
VW | Northwestern University | Brain Lower Grade Glioma | NCH |
VX | Northwestern University | Stomach adenocarcinoma | NCH |
VZ | Albert Einstein Medical Center | Pheochromocytoma and Paraganglioma | NCH |
W2 | Medical College of Wisconsin | Pheochromocytoma and Paraganglioma | NCH |
W3 | John Wayne Cancer Center | Skin Cutaneous Melanoma | NCH |
W4 | University of North Carolina | Testicular Germ Cell Tumors | NCH |
W5 | Mayo Clinic Rochester | Cholangiocarcinoma | NCH |
W6 | UCSF | Cholangiocarcinoma | NCH |
W7 | Garvan Institute of Medical Research | Cholangiocarcinoma | NCH |
W8 | Greenville Health System | Breast invasive carcinoma | NCH |
W9 | University of Kansas | Brain Lower Grade Glioma | NCH |
WA | University of Schleswig-Holstein | Head and Neck squamous cell carcinoma | NCH |
WB | Erasmus MC | Pheochromocytoma and Paraganglioma | NCH |
WC | MD Anderson | Uveal Melanoma | NCH |
WD | Emory University | Cholangiocarcinoma | NCH |
WE | Norfolk and Norwich Hospital | Skin Cutaneous Melanoma | NCH |
WF | Greenville Health System | Pancreatic adenocarcinoma | NCH |
WG | Greenville Health System | Lung squamous cell carcinoma | NCH |
WH | Greenville Health System | Brain Lower Grade Glioma | NCH |
WJ | Greenville Health System | Liver hepatocellular carcinoma | NCH |
WK | Brigham and Women's Hospital | Sarcoma | NCH |
WL | University of Kansas | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
WM | University of Kansas | Kidney renal clear cell carcinoma | NCH |
WN | University of Kansas | Kidney renal papillary cell carcinoma | NCH |
WP | University of Kansas | Sarcoma | NCH |
WQ | University of Kansas | Liver hepatocellular carcinoma | NCH |
WR | University of Kansas | Ovarian serous cystadenocarcinoma | NCH |
WS | University of Kansas | Colon adenocarcinoma | NCH |
WT | University of Kansas | Breast invasive carcinoma | NCH |
WU | Wake Forest University | Colon adenocarcinoma | NCH |
WW | Wake Forest University | Prostate adenocarcinoma | NCH |
WX | Yale University | Liver hepatocellular carcinoma | NCH |
WY | Johns Hopkins | Brain Lower Grade Glioma | NCH |
WZ | International Genomics Consortium | Testicular Germ Cell Tumors | NCH |
X2 | University of Washington | Sarcoma | NCH |
X3 | Cleveland Clinic Foundation | Testicular Germ Cell Tumors | NCH |
X4 | Institute for Medical Research | Prostate adenocarcinoma | NCH |
X5 | Institute of Human Virology Nigeria | Bladder Urothelial Carcinoma | NCH |
X6 | University of Iowa | Sarcoma | NCH |
X7 | ABS IUPUI | Thymoma | NCH |
X8 | St. Joseph's Hospital Arizona | Esophageal carcinoma | NCH |
X9 | University of California, Davis | Sarcoma | NCH |
XA | University of Minnesota | Prostate adenocarcinoma | NCH |
XB | Albert Einstein Medical Center | Esophageal carcinoma | NCH |
XC | Albert Einstein Medical Center | Lung squamous cell carcinoma | NCH |
XD | Providence Portland Medical Center | Pancreatic adenocarcinoma | NCH |
XE | University of Southern California | Testicular Germ Cell Tumors | NCH |
XF | University of Southern California | Bladder Urothelial Carcinoma | NCH |
XG | BLN UT Southwestern Medical Center at Dallas | Pheochromocytoma and Paraganglioma | NCH |
XH | BLN Baylor | Thymoma | NCH |
XJ | University of Kansas | Prostate adenocarcinoma | NCH |
XK | Mayo Clinic Arizona | Prostate adenocarcinoma | NCH |
XM | MSKCC | Thymoma | NCH |
XN | University of Sao Paulo | Pancreatic adenocarcinoma | NCH |
XP | University of Sao Paulo | Esophageal carcinoma | NCH |
XQ | University of Sao Paulo | Prostate adenocarcinoma | NCH |
XR | University of Sao Paulo | Liver hepatocellular carcinoma | NCH |
XS | University of Sao Paulo | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
XT | Johns Hopkins | Mesothelioma | NCH |
XU | University Health Network | Thymoma | NCH |
XV | Capital Biosciences | Skin Cutaneous Melanoma | NCH |
XX | Spectrum Health | Breast invasive carcinoma | NCH |
XY | Spectrum Health | Testicular Germ Cell Tumors | NCH |
Y3 | University of New Mexico | Acute Myeloid Leukemia | NCH |
Y5 | University of Arizona | Sarcoma | NCH |
Y6 | University of Arizona | Prostate adenocarcinoma | NCH |
Y8 | Spectrum Health | Kidney renal papillary cell carcinoma | NCH |
YA | Spectrum Health | Liver hepatocellular carcinoma | NCH |
YB | Spectrum Health | Pancreatic adenocarcinoma | NCH |
YC | Spectrum Health | Bladder Urothelial Carcinoma | NCH |
YD | Spectrum Health | Skin Cutaneous Melanoma | NCH |
YF | University of Puerto Rico | Bladder Urothelial Carcinoma | NCH |
YG | University of Puerto Rico | Skin Cutaneous Melanoma | NCH |
YH | Stanford University | Pancreatic adenocarcinoma | NCH |
YJ | Stanford University | Prostate adenocarcinoma | NCH |
YL | PROCURE Biobank | Prostate adenocarcinoma | NCH |
YN | University of Arizona | Skin Cutaneous Melanoma | NCH |
YR | Barretos Cancer Hospital | Cholangiocarcinoma | NCH |
YS | Barretos Cancer Hospital | Mesothelioma | NCH |
YT | Barretos Cancer Hospital | Thymoma | NCH |
YU | Barretos Cancer Hospital | Testicular Germ Cell Tumors | NCH |
YV | MSKCC | Uveal Melanoma | NCH |
YW | Albert Einstein Medical Center | Sarcoma | NCH |
YX | Emory University | Stomach adenocarcinoma | NCH |
YY | Roswell Park | Pancreatic adenocarcinoma | NCH |
YZ | The Ohio State University | Uveal Melanoma | NCH |
Z2 | IDI-IRCCS | Skin Cutaneous Melanoma | NCH |
Z3 | UCLA | Sarcoma | NCH |
Z4 | Cureline | Sarcoma | NCH |
Z5 | Cureline | Pancreatic adenocarcinoma | NCH |
Z6 | Cureline | Esophageal carcinoma | NCH |
Z7 | John Wayne Cancer Center | Breast invasive carcinoma | NCH |
Z8 | John Wayne Cancer Center | Pancreatic adenocarcinoma | NCH |
ZA | Candler | Stomach adenocarcinoma | NCH |
ZB | Thoraxklinik | Thymoma | NCH |
ZC | University of Mannheim | Thymoma | NCH |
ZD | ILSbio | Cholangiocarcinoma | NCH |
ZE | Spectrum Health | Lung squamous cell carcinoma | NCH |
ZF | University of Sheffield | Bladder Urothelial Carcinoma | NCH |
ZG | University Medical Center Hamburg-Eppendorf | Prostate adenocarcinoma | NCH |
ZH | University of North Carolina | Cholangiocarcinoma | NCH |
ZJ | NCI HRE Branch | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
ZK | University of New Mexico | Cholangiocarcinoma | NCH |
ZL | Valley Hospital | Thymoma | NCH |
ZM | University of Ulm | Testicular Germ Cell Tumors | NCH |
ZN | Brigham and Women's Hospital Division of Thoracic Surgery | Mesothelioma | NCH |
ZP | Medical College of Wisconsin | Liver hepatocellular carcinoma | NCH |
ZQ | Tayside Tissue Bank | Stomach adenocarcinoma | NCH |
ZR | Tayside Tissue Bank | Esophageal carcinoma | NCH |
ZS | Tayside Tissue Bank | Liver hepatocellular carcinoma | NCH |
ZT | International Genomics Consortium | Thymoma | NCH |
ZU | Spectrum Health | Cholangiocarcinoma | NCH |
ZW | University of Alabama | Pancreatic adenocarcinoma | NCH |
ZX | University of Alabama | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |